Radioactive Triolein Test in Malignant Disease
Author Information
Author(s): A. Centi Colella, W. S. Reith, E. S. Williams
Primary Institution: Institute of Nuclear Medicine, Middlesex Hospital Medical School
Hypothesis
How does malignant disease affect the results of the 131I-triolein fat absorption test?
Conclusion
The blood radioactivity was found to be lower in patients with malignant disease compared to normal subjects.
Supporting Evidence
- The mean blood radioactivity was significantly lower in the malignant group compared to normal subjects.
- Successful treatment improved blood radioactivity levels towards normal.
- Statistical analysis showed significant differences in blood radioactivity between groups.
Takeaway
This study looked at how a special fat test works in people with cancer, finding that their blood showed less radioactivity than healthy people.
Methodology
Patients ingested a labelled fatty meal, and blood samples were taken at intervals to measure radioactivity.
Limitations
The technique used has limited utility and results should be interpreted with caution.
Participant Demographics
22 males and 12 females, aged 13-89 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website